当前位置：首页 SCI 期刊医学 Inflammopharmacology(非官网)

InflammopharmacologySCIE

国际简称：INFLAMMOPHARMACOLOGY 参考译名：炎症药理学

中科院分区
2区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：0925-4692; E-ISSN：1568-5608; 是否OA：未开放; 是否预警：否; TOP期刊：是

出版信息：: 出版地区：NETHERLANDS; 出版商：Springer International Publishing; 出版语言：English; 出版周期：6 issues per year; 出版年份：1991; 研究方向：IMMUNOLOGYTOXICOLOGY-TOXICOLOGY

评价信息：: 影响因子：4.6; H-index：45; CiteScore指数：8; SJR指数：0.952; SNIP指数：1.006

发文数据：: Gold OA文章占比：20.93%; 研究类文章占比：65.78%; 年发文量：263; 自引率：0.0344...; 开源占比：0.128; 出版撤稿占比：0; 出版国人文章占比：0.15; OA被引用占比：0.0576...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Inflammopharmacology期刊介绍

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states

-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs

-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents

-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain

-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs

-Muscle-immune interactions during inflammation [...]

期刊简介Inflammopharmacology期刊介绍

《Inflammopharmacology》自1991出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：
国际TOP期刊
医学
TOXICOLOGY
SCIE
中科院2区
非预警

Cite Score数据（2024年最新版）Inflammopharmacology Cite Score数据

CiteScore：8
SJR：0.952
SNIP：1.006

学科类别	分区	排名	百分位
大类：Medicine 小类：Pharmacology (medical)	Q1	37 / 272	86%
大类：Medicine 小类：Pharmacology	Q1	70 / 313	77%
大类：Medicine 小类：Immunology	Q2	80 / 236	66%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Inflammopharmacology 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	2区	TOXICOLOGY 毒理学 IMMUNOLOGY 免疫学	1区 3区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Inflammopharmacology JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q2	56 / 181	69.3%
学科：TOXICOLOGY	SCIE	Q1	17 / 106	84.4%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q1	37 / 181	79.83%
学科：TOXICOLOGY	SCIE	Q1	17 / 106	84.43%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
CHINA MAINLAND79
India76
Brazil60
Iran39
USA23
Pakistan22
Australia20
Egypt18
Saudi Arabia16
England13

本刊中国学者近年发表论文

1、Diosmetin alleviates acute lung injury caused by lipopolysaccharide by targeting barrier function
Author: Xia, Jiying; Li, Junhong; Deng, Mengsheng; Yin, Fei; Liu, Jianhui; Wang, Jianmin

Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-023-01228-7
2、Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases
Author: Zhou, Peng; Ma, Yao-yao; Zhao, Xiao-ni; Hua, Fang

Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-022-01130-8
3、Inhibition of STAT3 phosphorylation by colchicine regulates NLRP3 activation to alleviate sepsis-induced acute lung injury
Author: Liu, Yuanshui; Yang, Hang; Zhu, Fei; Ouyang, Yanhong; Pan, Pinhua

Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-023-01199-9
4、Adalimumab combined with erythropoietin improves recovery from spinal cord injury by suppressing microglial M1 polarization-mediated neural inflammation and apoptosis
Author: Liu, Yanming; Zhang, Feiyue; Sun, Qi; Liang, Lichao

Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. 31, Issue 2, pp. 887-897. DOI: 10.1007/s10787-022-01090-z
5、Suprabasin-derived polypeptides: SBSN(50-63) induces inflammatory response via TLR4-mediated mast cell activation
Author: Zhou, Tong; Du, Xueshan; Zhang, Lei; Zheng, Yi; Jia, Tao; Song, Xiangjin; Che, Delu; Geng, Songmei

Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-023-01137-9
6、Synovial mesenchymal stem cell-derived exosomal microRNA-320c facilitates cartilage damage repair by targeting ADAM19-dependent Wnt signalling in osteoarthritis rats
Author: Kong, Ruina; Zhang, Ju; Ji, Lianmei; Yu, Yiyi; Gao, Jie; Zhao, Dongbao

Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. 31, Issue 2, pp. 915-926. DOI: 10.1007/s10787-023-01142-y
7、A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis
Author: Guo, Haohao; Wang, Ziyang; Ma, Runsheng; Chen, Xin; Li, Hongqiang; Tang, Yifeng; Du, Gongbo; Zhang, Yifei; Yin, Detao

Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. 31, Issue 2, pp. 745-754. DOI: 10.1007/s10787-023-01148-6
8、Daidzein attenuated paclitaxel-induced neuropathic pain via the down-regulation of TRPV1/P2Y and up-regulation of Nrf2/HO-1 signaling
Author: Zafar, Sana; Luo, Yong; Zhang, Li; Li, Chang Hu; Khan, Adnan; Khan, Muhammad Ibrar; Shah, Kifayatullah; Seo, Eun Kyoung; Wang, Feng; Khan, Salman

Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-023-01225-w